Started in Boston in 2014, BiBo kicked off its Shanghai R&D center in 2017 and launched three GMP manufacturing plants since then. As a full life-cycle, full spectrum CDMO, BiBo established the world first and largest 30kL mammalian cell production line to ensure our clients gain a sufficient supply of biologics products at the most inexpensive cost.